Using digital health technologies to optimise antimicrobial use globally.

Publication date: Nov 14, 2024

Digital health technology (DHT) describes tools and devices that generate or process health data. The application of DHTs could improve the diagnosis, treatment, and surveillance of bacterial infection and the prevention of antimicrobial resistance (AMR). DHTs to optimise antimicrobial use are rapidly being developed. To support the global adoption of DHTs and the opportunities offered to optimise antimicrobial use consensus is needed on what data are required to support antimicrobial decision making. This Series paper will explore bacterial AMR in humans and the need to optimise antimicrobial use in response to this global threat. It will also describe state-of-the-art DHTs to optimise antimicrobial prescribing in high-income and low-income and middle-income countries, and consider what fundamental data are ideally required for and from such technologies to support optimised antimicrobial use.

Open Access PDF

Concepts Keywords
Antimicrobial Amr
Bacterial Antimicrobial
Global Bacterial
Income Data
Prescribing Describes
Devices
Dht
Dhts
Digital
Generate
Global
Income
Optimise
Process
Required

Semantics

Type Source Name
drug DRUGBANK Stanolone
disease IDO process
disease MESH bacterial infection
drug DRUGBANK Coenzyme M
disease MESH Infections
disease MESH Infectious Diseases
disease IDO quality
disease MESH malaria
pathway KEGG Malaria
drug DRUGBANK Water
disease IDO infection
disease IDO organism
disease IDO bacteria
disease MESH infection transmission
disease MESH critically ill
disease IDO host
disease IDO pathogen
disease MESH Lifestyle
disease IDO history
disease MESH COVID 19
disease MESH morbidity
disease MESH nutritional status
disease MESH complications
disease MESH Clostridioides difficile infection
disease IDO algorithm
disease IDO susceptibility
drug DRUGBANK Etoperidone
drug DRUGBANK Methyl isocyanate
disease MESH pneumonia
disease MESH cellulitis
disease IDO pathogen host
drug DRUGBANK Spinosad
disease IDO site
disease IDO intervention
disease MESH Privacy
disease MESH ototoxicity
disease MESH tic
drug DRUGBANK Linezolid
disease IDO assay
disease IDO toxin
disease IDO production
disease IDO commensal
drug DRUGBANK Gold
pathway REACTOME Immune System
disease MESH malignancy
disease IDO immunodeficiency
disease MESH Comorbidity
disease MESH relapse
disease MESH anaphylaxis
drug DRUGBANK Trestolone
disease MESH allergies
disease IDO blood
disease IDO role
drug DRUGBANK Tmr
disease MESH Emergencies
disease MESH Cystic Fibrosis
disease MESH non communicable diseases
disease IDO antibiotic resistance
disease IDO virulence
drug DRUGBANK Folic Acid
drug DRUGBANK Cysteamine
disease IDO acute infection
drug DRUGBANK Phenoxymethylpenicillin
disease MESH bloodstream infections
disease MESH chronic diseases
disease MESH death
disease MESH fatal outcome

Original Article

(Visited 1 times, 1 visits today)